Papers
Research literature with structured metadata.
Trials
Registered studies by status, phase, and compound.
Topics
Indications and themes psychedelics are researched for.
Compounds
Evidence across molecules with rich data.
Countries
Regulation, access, and research activity by region.
Stakeholders
Organizations shaping the space across research, policy, and funding.
People
Investigators, clinicians, and authors with mapped output.
Courses
Training programs and certifications across modalities.
Events
Conferences, workshops, and convenings by date and focus.
Research recaps
Monthly evidence summaries with key takeaways.
Map of research
Landscape view of trials, compounds, and outcomes.
Newsletter
Weekly or daily updates on trials, publications, analysis, and more.
Research Groups
Worldwide map of psychedelic research centres by region.
Research Network
Interactive co-authorship map of psychedelic researchers.
Top papers
Find needles in the haystack of psychedelic research per topic.
This theory-building paper (2020) argues for the synergy between Acceptance and Commitment Therapy (ACT) and psilocybin-assisted therapy, describes the process, and limitations to using this framework.
This survey study (n=985) finds that psychological flexibility fully mediated the effects of mystical/peak experiences on depression/anxiety.
This theory-building paper (2020) presents the ACE (Accept, Connect, Embody) model and how it's being used in a trial (Psilodep 2) with psilocybin-assisted therapy for depression.
This theoretical paper (2019) proposes Contextual Behavioural Science (CBS) as an ideal framework for understanding psychedelic experiences and therapeutic change. The authors argue that CBS-based therapies, such as Acceptance and Commitment Therapy (ACT), are uniquely positioned to deepen and maintain the acute effects of psychedelic-assisted therapy.